Oppenheimer & CO Inc Agios Pharmaceuticals, Inc. Transaction History

Oppenheimer & CO Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 11, 2020	SELL	$34.45 - $53.48 $1.73 Million - $2.69 Million	-50,340 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$31.52 - $53.81 $6,304 - $10,762	-200 Reduced 0.4%	50,340 $1.79 Million
Q4 2019 Feb 07, 2020	SELL	$30.08 - $50.59 $220,636 - $371,077	-7,335 Reduced 12.67%	50,540 $2.41 Million
Q2 2019 Aug 09, 2019	SELL	$46.17 - $68.1 $288,654 - $425,761	-6,252 Reduced 9.75%	57,875 $2.89 Million
Q1 2019 Apr 24, 2019	BUY	$45.92 - $67.67 $24,567 - $36,203	535 Added 0.84%	64,127 $4.33 Million
Q4 2018 Jan 29, 2019	BUY	$42.73 - $76.53 $427,855 - $766,294	10,013 Added 18.69%	63,592 $2.93 Million
Q3 2018 Oct 26, 2018	BUY	$71.67 - $91.95 $35,763 - $45,883	499 Added 0.94%	53,579 $4.13 Million
Q2 2018 Aug 10, 2018	BUY	$73.22 - $99.55 $2.46 Million - $3.35 Million	33,643 Added 173.09%	53,080 $4.47 Million
Q1 2018 May 01, 2018	SELL	$59.83 - $86.53 $39,607 - $57,282	-662 Reduced 3.29%	19,437 $1.59 Million
Q4 2017 Feb 07, 2018	SELL	$52.12 - $72.33 $70,153 - $97,356	-1,346 Reduced 6.28%	20,099 $1.15 Million
Q3 2017 Nov 09, 2017	BUY	$54.89 - $67.12 $1.18 Million - $1.44 Million	21,445	21,445 $1.43 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.